Quick Answer
Bioventus Inc. reported Total Assets of $683.56 million for fiscal year 2025.
Bioventus Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $683.56M | -6.1% |
| 2024 | $727.96M | -10.2% |
| 2023 | $810.91M | -40.9% |
| 2022 | $1.37B | +12.0% |
| 2021 | $1.23B | +147.9% |
| 2020 | $494.47M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $701.59M | -8.8% | -0.7% |
| June 30, 2025 | $706.79M | -10.8% | +2.2% |
| March 31, 2025 | $691.41M | -12.9% | -5.0% |
| December 31, 2024 | $727.96M | -10.2% | -5.4% |
| September 30, 2024 | $769.49M | -5.1% | -2.9% |
| June 30, 2024 | $792.17M | -5.4% | -0.3% |
| March 31, 2024 | $794.24M | -10.5% | -2.1% |
| December 31, 2023 | $810.91M | -40.9% | -0.0% |
- Bioventus Inc. showed a decrease of -6.1% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Bioventus Inc.’s total assets has grown by 38.2% (from $494.47 million to $683.56 million).
- The most recent figure is from Bioventus Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: